Biosimilars and interchangeable biologics: News to watch

Biosimilars are slowly gaining traction, but legal barriers remain. Find out what to know.

Three ways to reign in drug costs, regardless of who becomes president

It's time for stakeholders to cooperate in order to limit the wasted spending. Read more.

Medicare Part D patients not taking blood pressure meds correctly

Expert recommends specific actions for managed care execs. Read more.

MOST POPULAR IN PHARMACY

How the presidential candidates plan to rein in pharma costs

October 31, 2016

Technology Survey

What technology is your organization using? Please take our quick technology survey. You'll be entered to win a $200 visa gift card. Take the survey.

Get the free app!

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us